AQP3 and colon adenocarcinoma: In human colon adenocarcinoma HCT8 cells, treatment with DDAVP, a stable analog of the hormone vasopressin, was previously shown to significantly reduce membrane expression of AQP3, resulting in decreased cell viability [6].